EUVIMEDEUVIMED entdecken
Open Access

Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse model

Murali K Yanda iD, Adi Zeidan, Liudmila Cebotaru iD

American Journal of Physiology-Gastrointestinal and Liver Physiology · 2023

DOI: 10.1152/ajpgi.00255.2022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2023. Verfasst von Murali K Yanda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine and Physiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Recessive. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ARPKD is a multiorgan genetic disorder resulting in newborn morbidity and mortality. There is a critical need for new therapies to treat this disease. We show that persistent cholangiocytes proliferation occurs in a mouse model of ARPKD along with mislocalized CFTR and misregulated heat shock proteins. We found that VX-809, a CFTR modulator, inhibits proliferation and limits bile duct malformation. The data provide a therapeutic pathway for strategies to treat ADPKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal RecessiveHumansMiceAnimalsCystic Fibrosis Transmembrane Conductance RegulatorReceptors, Cell SurfaceLiver CirrhosisHeat-Shock ProteinsAminopyridinesBenzodioxoles

Stichwörter der Autor:innen

autosomal recessive polycystic kidney diseasebiliary ductscystic fibrosis transmembrane conductance regulatorfibrocystin/polyductinheat shock proteinsprimary cilia

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorReceptors, Cell SurfaceHeat-Shock ProteinslumacaftorAminopyridinesBenzodioxolesPkhd1 protein, mouse

Autor:innen und Institutionen

  • Departments of Medicine and Physiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.

ORCID-Profile: Murali K Yanda, Liudmila Cebotaru

Förderung

  • NIDDK NIH HHS
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Yanda, M. K., Zeidan, A., & Cebotaru, L. (2023). Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse model. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00255.2022

Vancouver

Yanda MK, Zeidan A, Cebotaru L. Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse model. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2023. doi:10.1152/ajpgi.00255.2022

BibTeX
@article{Yanda2023,
  author = {Yanda, Murali K and Zeidan, Adi and Cebotaru, Liudmila},
  title = {Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse model},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2023},
  doi = {10.1152/ajpgi.00255.2022}
}
Kostenlos starten →